Home » Author Archive

Image for Head to Head Analysis: Metals Acquisition (NYSE:MTAL) & Pure Energy Minerals (OTCMKTS:PEMIF)

Head to Head Analysis: Metals Acquisition (NYSE:MTAL) & Pure Energy Minerals (OTCMKTS:PEMIF)

Metals Acquisition (NYSE:MTAL – Get Free Report) and Pure Energy Minerals (OTCMKTS:PEMIF – Get Free Report) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two companies... More of this article »
Image for Top KingWin (NASDAQ:TCJH) versus Visa (NYSE:V) Head-To-Head Contrast

Top KingWin (NASDAQ:TCJH) versus Visa (NYSE:V) Head-To-Head Contrast

Top KingWin (NASDAQ:TCJH – Get Free Report) and Visa (NYSE:V – Get Free Report) are both finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability,... More of this article »
Image for Critical Contrast: Evaxion Biotech A/S (NASDAQ:EVAX) versus Jasper Therapeutics (NASDAQ:JSPR)

Critical Contrast: Evaxion Biotech A/S (NASDAQ:EVAX) versus Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics (NASDAQ:JSPR – Get Free Report) and Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based... More of this article »
Image for Financial Analysis: Sonendo (SONX) and Its Competitors

Financial Analysis: Sonendo (SONX) and Its Competitors

Sonendo (NYSE:SONX – Get Free Report) is one of 14 publicly-traded companies in the “Dental equipment & supplies” industry, but how does it contrast to its competitors? We will compare Sonendo to similar companies... More of this article »
Image for Wells Fargo & Company Boosts Cadence Design Systems (NASDAQ:CDNS) Price Target to $350.00

Wells Fargo & Company Boosts Cadence Design Systems (NASDAQ:CDNS) Price Target to $350.00

Cadence Design Systems (NASDAQ:CDNS – Free Report) had its price objective lifted by Wells Fargo & Company from $330.00 to $350.00 in a research report released on Tuesday, Benzinga reports. The firm currently has an overweight... More of this article »
Image for Cumberland Pharmaceuticals (NASDAQ:CPIX) Research Coverage Started at StockNews.com

Cumberland Pharmaceuticals (NASDAQ:CPIX) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research report report published on Tuesday morning. The firm issued a hold rating on the specialty pharmaceutical company’s... More of this article »
Image for Bio-Path (NASDAQ:BPTH) Earns Sell Rating from Analysts at StockNews.com

Bio-Path (NASDAQ:BPTH) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research report released on Tuesday morning. The brokerage issued a sell rating on the stock. Separately, Roth Mkm upped their target price... More of this article »
Image for Molson Coors Beverage (NYSE:TAP) Price Target Raised to $66.00 at Citigroup

Molson Coors Beverage (NYSE:TAP) Price Target Raised to $66.00 at Citigroup

Molson Coors Beverage (NYSE:TAP – Free Report) had its price target lifted by Citigroup from $63.00 to $66.00 in a research report released on Tuesday, Benzinga reports. The brokerage currently has a neutral rating on the stock. A... More of this article »
Image for Streamline Health Solutions (NASDAQ:STRM) Earns Sell Rating from Analysts at StockNews.com

Streamline Health Solutions (NASDAQ:STRM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Free Report) in a report published on Tuesday. The brokerage issued a sell rating on the stock. Streamline Health Solutions Stock Down 7.0... More of this article »
Image for Cencora, Inc. (NYSE:COR) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Cencora, Inc. (NYSE:COR) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Cencora, Inc. (NYSE:COR – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eight ratings firms that are currently covering the stock, MarketBeat.com reports. Three research analysts have... More of this article »
Image for Royal Bank of Canada Increases 4D Molecular Therapeutics (NASDAQ:FDMT) Price Target to $40.00

Royal Bank of Canada Increases 4D Molecular Therapeutics (NASDAQ:FDMT) Price Target to $40.00

4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) had its price objective hoisted by Royal Bank of Canada from $35.00 to $40.00 in a research note published on Monday, Benzinga reports. They currently have an outperform rating... More of this article »
Image for Head to Head Analysis: ARQ (ARQ) and Its Peers

Head to Head Analysis: ARQ (ARQ) and Its Peers

ARQ (NASDAQ:ARQ – Get Free Report) is one of 19 publicly-traded companies in the “Miscellaneous chemical products” industry, but how does it contrast to its peers? We will compare ARQ to related companies based on... More of this article »
Image for Crown Castle Inc. (NYSE:CCI) Given Consensus Recommendation of “Hold” by Brokerages

Crown Castle Inc. (NYSE:CCI) Given Consensus Recommendation of “Hold” by Brokerages

Crown Castle Inc. (NYSE:CCI – Get Free Report) has earned a consensus recommendation of “Hold” from the fourteen research firms that are presently covering the stock, Marketbeat.com reports. Eight equities research... More of this article »
Image for Analysts Set KKR & Co. Inc. (NYSE:KKR) Target Price at $90.64

Analysts Set KKR & Co. Inc. (NYSE:KKR) Target Price at $90.64

Shares of KKR & Co. Inc. (NYSE:KKR – Get Free Report) have received a consensus rating of “Moderate Buy” from the thirteen analysts that are covering the firm, MarketBeat Ratings reports. One equities research... More of this article »
Image for Kemper (NYSE:KMPR) Given Market Outperform Rating at JMP Securities

Kemper (NYSE:KMPR) Given Market Outperform Rating at JMP Securities

JMP Securities reaffirmed their market outperform rating on shares of Kemper (NYSE:KMPR – Free Report) in a report released on Monday morning, Benzinga reports. JMP Securities currently has a $75.00 target price on the insurance... More of this article »
Image for Align Technology (NASDAQ:ALGN) Price Target Raised to $320.00 at UBS Group

Align Technology (NASDAQ:ALGN) Price Target Raised to $320.00 at UBS Group

Align Technology (NASDAQ:ALGN – Free Report) had its target price lifted by UBS Group from $280.00 to $320.00 in a research report sent to investors on Monday morning, Benzinga reports. UBS Group currently has a neutral rating... More of this article »
Image for Goosehead Insurance (NASDAQ:GSHD) Given “Market Outperform” Rating at JMP Securities

Goosehead Insurance (NASDAQ:GSHD) Given “Market Outperform” Rating at JMP Securities

JMP Securities reissued their market outperform rating on shares of Goosehead Insurance (NASDAQ:GSHD – Free Report) in a report published on Monday, Benzinga reports. The firm currently has a $100.00 price target on the stock. Several... More of this article »
Image for Regeneron Pharmaceuticals (NASDAQ:REGN) Rating Reiterated by Cantor Fitzgerald

Regeneron Pharmaceuticals (NASDAQ:REGN) Rating Reiterated by Cantor Fitzgerald

Cantor Fitzgerald reissued their neutral rating on shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) in a research report report published on Monday, Benzinga reports. The firm currently has a $925.00 target price... More of this article »
Image for Vericity (VERY) and Its Peers Head to Head Comparison

Vericity (VERY) and Its Peers Head to Head Comparison

Vericity (NASDAQ:VERY – Get Free Report) is one of 41 public companies in the “Life insurance” industry, but how does it contrast to its rivals? We will compare Vericity to similar companies based on the strength... More of this article »
Image for Head to Head Survey: Caribou Biosciences (NASDAQ:CRBU) and Tourmaline Bio (NASDAQ:TRML)

Head to Head Survey: Caribou Biosciences (NASDAQ:CRBU) and Tourmaline Bio (NASDAQ:TRML)

Caribou Biosciences (NASDAQ:CRBU – Get Free Report) and Tourmaline Bio (NASDAQ:TRML – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based... More of this article »
Image for Netflix (NASDAQ:NFLX) Price Target Raised to $550.00

Netflix (NASDAQ:NFLX) Price Target Raised to $550.00

Netflix (NASDAQ:NFLX – Free Report) had its price target increased by Deutsche Bank Aktiengesellschaft from $525.00 to $550.00 in a research report report published on Monday, Marketbeat reports. Deutsche Bank Aktiengesellschaft... More of this article »
Image for Interface (NASDAQ:TILE) Receives New Coverage from Analysts at Barrington Research

Interface (NASDAQ:TILE) Receives New Coverage from Analysts at Barrington Research

Barrington Research initiated coverage on shares of Interface (NASDAQ:TILE – Free Report) in a report released on Monday morning, MarketBeat.com reports. The firm issued an outperform rating and a $20.00 target price on the textile... More of this article »
Image for Intuitive Machines (LUNR) & Its Peers Critical Analysis

Intuitive Machines (LUNR) & Its Peers Critical Analysis

Intuitive Machines (NASDAQ:LUNR – Get Free Report) is one of 19 public companies in the “Search & navigation equipment” industry, but how does it contrast to its rivals? We will compare Intuitive Machines to... More of this article »
Image for United States Antimony (NYSE:UAMY) Earns Hold Rating from Analysts at StockNews.com

United States Antimony (NYSE:UAMY) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of United States Antimony (NYSE:UAMY – Free Report) in a research note released on Tuesday. The firm issued a hold rating on the stock. United States Antimony Stock Performance Shares of... More of this article »
Image for CACI International (NYSE:CACI) Cut to “Hold” at StockNews.com

CACI International (NYSE:CACI) Cut to “Hold” at StockNews.com

StockNews.com cut shares of CACI International (NYSE:CACI – Free Report) from a buy rating to a hold rating in a report published on Monday. Other analysts also recently issued reports about the company. Jefferies Financial Group... More of this article »